• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支架诱导新生内膜形成过程中I型胶原蛋白的翻译后修饰(PTM)网络图谱紊乱

Perturbed post-translational modification (PTM) network atlas of collagen I during stent-induced neointima formation.

作者信息

Sarohi Vivek, Basak Trayambak

机构信息

School of Biosciences and Bioengineering (SBB), Indian Institute of Technology (IIT)- Mandi, India; BioX Center, IIT-Mandi, Himachal Pradesh 175075, India.

School of Biosciences and Bioengineering (SBB), Indian Institute of Technology (IIT)- Mandi, India; BioX Center, IIT-Mandi, Himachal Pradesh 175075, India.

出版信息

J Proteomics. 2023 Mar 30;276:104842. doi: 10.1016/j.jprot.2023.104842. Epub 2023 Feb 11.

DOI:10.1016/j.jprot.2023.104842
PMID:36775122
Abstract

Myocardial infarction (MI) leading to heart failure contributes to almost 85% of deaths associated with CVDs. MI results from plaque formation in the coronary artery which leads to a lack of oxygen and nutrients in the myocardium. To date, stenting is a widely used gold-standard technique to maintain the proper blood flow through coronary circulation in the myocardium. Bare metal stents (BMS) and drug-eluting stents (DES) are majorly used in implantation. However, BMS and DES both can induce neointima formation by depositing excessive collagens in the coronary arteries leading to restenosis. Identification and quantitative analysis of site-specific post-translational modifications (PTMs) of deposited COL1A1 from neointima ECM are not known. Applying our in-house workflow, we re-analyzed a previously published mass-spectrometry data set to comprehensively map site-specific prolyl-hydroxylation, lysyl hydroxylation, and O-glycosylation sites in COL1A1 from neointima ECM. Furthermore, we quantitated the occupancy level of 9 3-hydroxyproline (3-HyP) sites, 2 hydroxylysine sites, and glycosylation microheterogeneity on 6 lysine sites of COL1A1. Although the total level of COL1A1 was decreased in DES-induced neointima, the occupancy levels of 2 3-HyP sites (P, and P) and 2 HyK (K and K) sites of COL1A1 were significantly (p < 0.05) elevated in DES-induced neointima compared to BMS-induced neointima. We also found O-glycosylation to be significantly elevated on 3 lysine sites (K, K, and K and K) of COL1A1 in DES-induced neointima compared to BMS-induced neointima. Taken together, our first comprehensive PTM analysis of COL1A1 reflected significant site-specific alterations that may play a very important role in the ECM remodeling during stent-induced neointima formation in MI patients. SIGNIFICANCE: The knowledge about site-specific post-translational modifications (PTMs) of collagen 1 deposited in the neointima ECM during the post-stenting restenosis process is absent. Here for the first time, we report the altered levels of COL1A1 PTMs during metal stent and drug-eluting stent-induced neointima formation. Our study showcases a novel ECM remodeling through site-specific collagen PTMs during stent-induced restenosis.

摘要

导致心力衰竭的心肌梗死(MI)导致了近85%的心血管疾病相关死亡。心肌梗死是由冠状动脉中形成斑块所致,这会导致心肌缺氧和营养物质缺乏。迄今为止,支架植入是一种广泛应用的金标准技术,用于维持心肌中冠状动脉循环的正常血流。裸金属支架(BMS)和药物洗脱支架(DES)主要用于植入。然而,BMS和DES都可通过在冠状动脉中沉积过多胶原蛋白导致内膜增生,进而引起再狭窄。目前尚不清楚来自新生内膜细胞外基质(ECM)的沉积型COL1A1的位点特异性翻译后修饰(PTM)的鉴定和定量分析情况。应用我们内部的工作流程,我们重新分析了一个先前发表的质谱数据集,以全面绘制来自新生内膜ECM的COL1A1中位点特异性脯氨酰羟化、赖氨酰羟化和O-糖基化位点。此外,我们定量了COL1A1的9个3-羟脯氨酸(3-HyP)位点、2个羟赖氨酸位点以及6个赖氨酸位点上糖基化微异质性的占据水平。尽管DES诱导的新生内膜中COL1A1的总水平降低,但与BMS诱导的新生内膜相比,DES诱导的新生内膜中COL1A1的2个3-HyP位点(P和P)和2个HyK(K和K)位点的占据水平显著升高(p<0.05)。我们还发现,与BMS诱导的新生内膜相比,DES诱导的新生内膜中COL1A1的3个赖氨酸位点(K、K以及K和K)上的O-糖基化显著升高。综上所述,我们对COL1A1的首次全面PTM分析反映了显著的位点特异性改变,这些改变可能在MI患者支架诱导的新生内膜形成过程中的ECM重塑中发挥非常重要的作用。意义:关于支架植入后再狭窄过程中沉积在新生内膜ECM中的胶原蛋白1的位点特异性翻译后修饰(PTM)的知识尚不存在。在此,我们首次报告了金属支架和药物洗脱支架诱导新生内膜形成过程中COL1A1 PTMs水平的改变。我们的研究展示了支架诱导再狭窄过程中通过位点特异性胶原蛋白PTM进行的新型ECM重塑。

相似文献

1
Perturbed post-translational modification (PTM) network atlas of collagen I during stent-induced neointima formation.支架诱导新生内膜形成过程中I型胶原蛋白的翻译后修饰(PTM)网络图谱紊乱
J Proteomics. 2023 Mar 30;276:104842. doi: 10.1016/j.jprot.2023.104842. Epub 2023 Feb 11.
2
Comprehensive Mapping and Dynamics of Site-Specific Prolyl-Hydroxylation, Lysyl-Hydroxylation and Lysyl O-Glycosylation of Collagens Deposited in ECM During Zebrafish Heart Regeneration.斑马鱼心脏再生过程中沉积在细胞外基质中的胶原蛋白位点特异性脯氨酰羟化、赖氨酰羟化和赖氨酰O-糖基化的综合图谱及动态变化
Front Mol Biosci. 2022 Jun 16;9:892763. doi: 10.3389/fmolb.2022.892763. eCollection 2022.
3
Quantitative proteomic profiling of extracellular matrix and site-specific collagen post-translational modifications in an model of lung fibrosis.肺纤维化模型中细胞外基质的定量蛋白质组学分析及位点特异性胶原蛋白的翻译后修饰
Matrix Biol Plus. 2019 Apr 13;1:100005. doi: 10.1016/j.mbplus.2019.04.002. eCollection 2019 Feb.
4
Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).全患者人群行经皮冠状动脉介入治疗后第一代或第二代药物洗脱支架或裸金属支架植入术后 2 年的结果:来自 PRODIGY 研究(支架内内膜增生分级后延长双联抗血小板治疗研究)的预先指定分析。
JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.
5
Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS).药物洗脱支架或裸金属支架植入后支架内再狭窄时最小管腔面积和内膜增生的血管内超声评估。北欧血管内超声研究(NIVUS)。
Cardiovasc Revasc Med. 2017 Dec;18(8):577-582. doi: 10.1016/j.carrev.2017.05.010. Epub 2017 May 12.
6
Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.裸金属支架置入术后基于导管的紫杉醇给药与药物洗脱支架在冠状动脉疾病支架内再狭窄高危患者中的比较。
Cardiovasc Revasc Med. 2017 Dec;18(8):596-600. doi: 10.1016/j.carrev.2017.05.018. Epub 2017 May 31.
7
Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries.细胞外基质蛋白质组学揭示了聚集蛋白聚糖和聚集蛋白聚糖酶在支架置入冠状动脉血管重构中的相互作用。
Circulation. 2018 Jan 9;137(2):166-183. doi: 10.1161/CIRCULATIONAHA.116.023381. Epub 2017 Oct 13.
8
Evaluation of in-stent neointimal tissue components using integrated backscatter intravascular ultrasound: comparison of drug-eluting stents and bare-metal stents.应用背向散射积分技术的血管内超声评价支架内新生内膜组织成分:药物洗脱支架与金属裸支架的对比。
Int J Cardiovasc Imaging. 2012 Oct;28(7):1635-41. doi: 10.1007/s10554-011-9997-9. Epub 2011 Dec 18.
9
The role of integrated backscatter intravascular ultrasound in characterizing bare metal and drug-eluting stent restenotic neointima as compared to optical coherence tomography.与光学相干断层扫描相比,集成背向散射血管内超声在表征裸金属支架和药物洗脱支架再狭窄新生内膜中的作用。
J Cardiol. 2014 Dec;64(6):488-95. doi: 10.1016/j.jjcc.2014.03.007. Epub 2014 Apr 29.
10
Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.心血管事件归因于支架失败而住院的患者中,在裸金属支架和第一代及第二代药物洗脱支架中,新生内膜和新生动脉粥样硬化特征:一项光学相干断层扫描研究。
EuroIntervention. 2018 Feb 2;13(15):e1831-e1840. doi: 10.4244/EIJ-D-17-00051.

引用本文的文献

1
Proteomic Analysis and 2-Hydroxyisobutyrylation Profiling in Metabolic Syndrome Induced Restenosis.代谢综合征诱导再狭窄中的蛋白质组学分析及2-羟基异丁酰化谱分析
Mol Cell Proteomics. 2025 Apr 24;24(6):100978. doi: 10.1016/j.mcpro.2025.100978.
2
Proteomic insights into the extracellular matrix: a focus on proteoforms and their implications in health and disease.蛋白质组学对外细胞基质的研究进展:重点关注蛋白质形式及其在健康和疾病中的意义。
Expert Rev Proteomics. 2024 Nov;21(11):463-481. doi: 10.1080/14789450.2024.2427136. Epub 2024 Nov 15.
3
ColPTMScape: An open access knowledge base for tissue-specific collagen PTM maps.
ColPTMScape:一个用于组织特异性胶原蛋白翻译后修饰图谱的开放获取知识库。
Matrix Biol Plus. 2024 Feb 29;22:100144. doi: 10.1016/j.mbplus.2024.100144. eCollection 2024 Jun.
4
Editorial: Volume II: fibrotic tissue remodeling as a driver of disease pathogenesis.社论:第二卷:纤维化组织重塑作为疾病发病机制的驱动因素。
Front Mol Biosci. 2024 Jan 16;11:1356591. doi: 10.3389/fmolb.2024.1356591. eCollection 2024.